Analysis On The Profit Quality Of Lukang Pharmaceutical

The development of the pharmaceutical industry is closely related to each of us.As a rigid demand,the periodicity of the pharmaceutical industry is not obvious.However,with the continuous promotion of the two-vote system,consistency evaluation and other national health care policies,China's pharmaceutical industry has also ushered in a short-term benign adjustment stage.At the same time,the increasingly serious aging of the population,the comprehensive opening of the two-child policy all kinds of external factors,However,the current antibiotic market is fraught with risks.In 2011,the so-called "most severe restriction and resistance order" was issued,which was implemented in the following year.Then antibiotic prices fell sharply and the market began to oversupply.In 2016,the market share of antibiotics in China's hospitals with the most important terminal level of drug sales has dropped out of the top 10.In 2018,the national health commission issued a notice,further emphasizing the need to strengthen the clinical management of antimicrobial drugs and limit the escalation of antimicrobial resistance once again.As one of the four bases of antibiotics in China,the performance of lukang medicine has been greatly impacted by the policy of "limited resistance".Since 2011,the company's annual net profit after deducting non-recurring gains and losses has been negative.In 2013,the company was able to avoid the "wearing a hat" crisis by relying on government transfer payment and equity transfer,and its performance in the following two years was also mediocre.It was not until 2016 that the company began to see substantial improvement in operation and steady growth in earnings.This paper starts from the financial statements of shandong kang pharmaceutical.Firstly,the five indicators of its earnings quality are analyzed by the methods of vertical trend analysis and horizontal comparative analysis,hoping to make a relatively complete and accurate evaluation of the current earnings quality of shandong kang pharmaceutical.Secondly,it analyzes the factors that may affect itsprofit quality,excavates the essence of the problems behind each standard,and finds out the reasons for the changes of each index.Finally,based on the previous analysis,this paper finds out the deficiencies in the current profit quality of enterprises,and puts forward targeted Suggestions on the profit quality of enterprises in combination with the current situation and development trend of the pharmaceutical industry and the antibiotic market,hoping to help enterprises improve their profit quality on the basis of improving their profit level.